| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.089 | 0.05 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.05 |